Ngā hua rapu - GIRNITA, Ada

Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor mā Girnita, Leonard, Girnita, Ada, Larsson, Olle

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Targeting the IGF-1R: The Tale of the Tortoise and the Hare mā Crudden, Caitrin, Girnita, Ada, Girnita, Leonard

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment mā Helgadottir, Hildur, Rocha Trocoli Drakensjö, Iara, Girnita, Ada

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Differences in cutaneous melanoma treatment and patient satisfaction mā Wikstrom, Jakob D., Lundeberg, Lena, Frohm-Nilsson, Margareta, Girnita, Ada

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Correction: Differences in cutaneous melanoma treatment and patient satisfaction mā Wikstrom, Jakob D., Lundeberg, Lena, Frohm-Nilsson, Margareta, Girnita, Ada

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Ten-year Follow-up Study of Grenz Ray Treatment for Lentigo Maligna and Early Lentigo Maligna Melanoma mā DRAKENSJÖ, Iara R. T., ROSEN, Einar, FROHM NILSSON, Margareta, GIRNITA, Ada

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation mā Girnita, Leonard, Worrall, Claire, Takahashi, Shin-Ichiro, Seregard, Stefan, Girnita, Ada

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation mā Suleymanova, Naida, Crudden, Caitrin, Worrall, Claire, Dricu, Anica, Girnita, Ada, Girnita, Leonard

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor mā Zheng, Huiyuan, Worrall, Claire, Shen, Hongchang, Issad, Tarik, Seregard, Stefan, Girnita, Ada, Girnita, Leonard

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

β-Arrestin–biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor–targeting antibodies in Ewing’s sarcoma mā Zheng, Huiyuan, Shen, Hongchang, Oprea, Iulian, Worrall, Claire, Stefanescu, Radu, Girnita, Ada, Girnita, Leonard

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey mā Crudden, Caitrin, Song, Dawei, Cismas, Sonia, Trocmé, Eric, Pasca, Sylvya, Calin, George A., Girnita, Ada, Girnita, Leonard

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma mā Yin, Shucheng, Girnita, Ada, Strömberg, Thomas, Khan, Zahidul, Andersson, Sandra, Zheng, Huiyuan, Ericsson, Christer, Axelson, Magnus, Nistér, Monica, Larsson, Olle, Ekström, Tomas J., Girnita, Leonard

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma mā ERIKSSON, Hanna, HANSSON, Johan, KRYNITZ, Britta, MASUCCI, Giuseppe, GIRNITA, Ada, LAPINS, Jan, HUEN, Auris O., TAWBI, Hussein A., DAVIES, Michael A., TETZLAFF, Michael T., CURRY, Jonathan L.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line mā Furuta, Haruka, Yoshihara, Hidehito, Fukushima, Toshiaki, Yoneyama, Yosuke, Ito, Akihiro, Worrall, Claire, Girnita, Ada, Girnita, Leonard, Yoshida, Minoru, Asano, Tomoichiro, Komada, Masayuki, Kataoka, Naoyuki, Chida, Kazuhiro, Hakuno, Fumihiko, Takahashi, Shin-Ichiro

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa